子宫癌前哨淋巴结活检的应用情况
该研究利用Perspective数据库分析2011至2015年接受子宫切除术的子宫内膜癌患者,评估前哨淋巴结活检的使用模式、预测因素及结局。在28,362例患者中,4.8%接受前哨淋巴结活检,且该比例逐年上升,机器人辅助子宫切除术中应用最多。微创子宫切除术中,前哨淋巴结活检较淋巴结清扫术住院时间和费用更低。
要点
- 2011至2015年子宫内膜癌前哨淋巴结活检使用率逐年上升,机器人辅助子宫切除术中应用最显著。
- 与开腹子宫切除术相比,腹腔镜(调整风险比2.45)和机器人辅助(调整风险比2.69)子宫切除术更可能行前哨淋巴结活检。
- 微创子宫切除术中,前哨淋巴结活检较淋巴结清扫术住院时间和费用更低。
核心结论
- 2011至2015年子宫内膜癌前哨淋巴结活检使用增加,在机器人辅助子宫切除术患者中增加最显著。
研究设计与样本
- 使用Perspective数据库识别2011至2015年接受子宫切除术的子宫癌女性。
- 通过账单和收费代码将患者分为接受淋巴结清扫术、前哨淋巴结活检或无淋巴结评估。
- 采用多变量模型分析前哨淋巴结活检使用的临床、人口学和医院特征。
- 比较不同淋巴结评估方法的住院时间和费用。
主要发现
- 在28,362例患者中,9,327例(32.9%)未行淋巴结评估,17,669例(62.3%)行淋巴结清扫术,1,366例(4.8%)行前哨淋巴结活检。
- 前哨淋巴结活检在开腹子宫切除术中占1.3%(95%置信区间,1.0-1.6%),腹腔镜子宫切除术中占3.4%(95%置信区间,2.7-4.1%),机器人辅助子宫切除术中占7.5%(95%置信区间,7.0-8.0%)。
- 在多变量模型中,较近的手术年份与前哨淋巴结活检的实施相关。
- 与开腹子宫切除术相比,腹腔镜(调整风险比,2.45;95%置信区间,1.89-3.18)和机器人辅助(调整风险比,2.69;95%置信区间,2.19-3.30)子宫切除术更可能行前哨淋巴结活检。
- 在微创子宫切除术女性中,前哨淋巴结活检较淋巴结清扫术住院时间和费用更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To limit the potential short and long-term morbidity of lymphadenectomy, sentinel lymph node biopsy has been proposed for endometrial cancer. The principle of sentinel lymph node biopsy relies on removal of a small number of lymph nodes that are the first drainage basins from a tumor and thus the most likely to harbor tumor cells. While the procedure may reduce morbidity, efficacy data are limited and little is known about how commonly the procedure is performed. OBJECTIVE: We examined the patterns and predictors of use of sentinel lymph node biopsy and outcomes of the procedure in women with endometrial cancer who underwent hysterectomy. STUDY DESIGN: We used the Perspective database to identify women with uterine cancer who underwent hysterectomy from 2011 through 2015. Billing and charge codes were used to classify women as having undergone lymphadenectomy, sentinel lymph node biopsy, or no nodal assessment. Multivariable models were used to examine clinical, demographic, and hospital characteristics with use of sentinel lymph node biopsy. Length of stay and cost were compared among the different methods of nodal assessment. RESULTS: Among 28,362 patients, 9327 (32.9%) did not undergo nodal assessment, 17,669 (62.3%) underwent lymphadenectomy, and 1366 (4.8%) underwent sentinel lymph node biopsy. Sentinel lymph node biopsy was performed in 1.3% (95% confidence interval, 1.0-1.6%) of abdominal hysterectomies, 3.4% (95% confidence interval, 2.7-4.1%) of laparoscopic hysterectomies, and 7.5% (95% confidence interval, 7.0-8.0%) of robotic-assisted hysterectomies. In a multivariable model, more recent year of surgery was associated with performance of sentinel lymph node biopsy. Compared to abdominal hysterectomy, those undergoing laparoscopic (adjusted risk ratio, 2.45; 95% confidence interval, 1.89-3.18) and robotic-assisted (adjusted risk ratio, 2.69; 95% confidence interval, 2.19-3.30) hysterectomy were more likely to undergo sentinel lymph node biopsy. Among women who underwent minimally invasive hysterectomy, length of stay and cost were lower for sentinel lymph node biopsy compared to lymphadenectomy. CONCLUSION: The use of sentinel lymph node biopsy for endometrial cancer increased from 2011 through 2015. The increased use was most notable in women who underwent a robotic-assisted hysterectomy.
引用
- Wright JD, Cham S, Chen L, et al. Utilization of sentinel lymph node biopsy for uterine cancer. Am J Obstet Gynecol. 2017. PMID: 28213057. doi:10.1016/j.ajog.2017.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。